470
Participants
Start Date
November 30, 2021
Primary Completion Date
December 27, 2023
Study Completion Date
January 19, 2024
LOU064 25 mg (b.i.d)
LOU064 25 mg was administered by oral route twice a day (b.i.d) as a tablet.
Placebo
Placebo
LOU064 25 mg (b.i.d) as a tablet.
LOU064 25 mg was administered by oral route twice a day (b.i.d) as a tablet in open label phase.
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sydney
Novartis Investigative Site, East Melbourne
Novartis Investigative Site, Parkville
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Pleven
Novartis Investigative Site, Szeged
Novartis Investigative Site, Taipei
Novartis Investigative Site, Torino
Novartis Investigative Site, Taipei
Novartis Investigative Site, Suwon
Novartis Investigative Site, Hwaseong-si
Novartis Investigative Site, Milan
Novartis Investigative Site, Chevy Chase
Novartis Investigative Site, Woodstock
Novartis Investigative Site, Albany
Novartis Investigative Site, Tallahassee
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Aventura
Finlay Medical Research, Greenacres City
Novartis Investigative Site, Sarasota
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Las Palmas de Gran Canaria
Novartis Investigative Site, Izmir
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Izmir
Novartis Investigative Site, Izmir
Novartis Investigative Site, Talas Kayseri
Novartis Investigative Site, Kayseri
Novartis Investigative Site, Daegu
Novartis Investigative Site, Columbus
Novartis Investigative Site, Toledo
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Athens
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Evansville
Novartis Investigative Site, Reims
Novartis Investigative Site, Sakarya
Novartis Investigative Site, Samsun
Novartis Investigative Site, Pisa
Novartis Investigative Site, Ancona
Novartis Investigative Site, Gwangju
Novartis Investigative Site, St Louis
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Pierre-Bénite
Novartis Investigative Site, North Little Rock
Novartis Investigative Site, Tulsa
Novartis Investigative Site, Rouen
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Austin
Novartis Investigative Site, El Paso
Novartis Investigative Site, Denver
Novartis Investigative Site, Sandy City
Novartis Investigative Site, Villahermosa
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Antony
Novartis Investigative Site, Bakersfield
Novartis Investigative Site, Lancaster
Novartis Investigative Site, Redwood City
Novartis Investigative Site, Bellingham
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Chandigarh
Novartis Investigative Site, Varanasi
Novartis Investigative Site, Madrid
Novartis Investigative Site, Singapore
Novartis Investigative Site, Nashik
Novartis Investigative Site, Izhevsk
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Belgavi
Novartis Investigative Site, Kolkata
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, La Plata
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Rosario
Novartis Investigative Site, Bahía Blanca
Novartis Investigative Site, Capital Federal
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Medellín
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Brno
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Pilsen
Novartis Investigative Site, Prague
Novartis Investigative Site, Nice
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Obihiro
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Kamimashi-gun
Novartis Investigative Site, Takatsuki
Novartis Investigative Site, Koto
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Carolina
Novartis Investigative Site, San Juan
Novartis Investigative Site, Incheon
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Alicante
Novartis Investigative Site, Aydin
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY